Ingevity Co. (NYSE:NGVT) Shares Bought by Sei Investments Co.

Sei Investments Co. raised its holdings in Ingevity Co. (NYSE:NGVT) by 23.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 235,854 shares of the company’s stock after purchasing an additional 44,782 shares during the period. Sei Investments Co. owned about 0.65% of Ingevity worth $9,611,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. KBC Group NV lifted its stake in Ingevity by 27.5% in the 4th quarter. KBC Group NV now owns 2,007 shares of the company’s stock valued at $82,000 after buying an additional 433 shares in the last quarter. Arizona State Retirement System lifted its stake in shares of Ingevity by 6.1% in the 4th quarter. Arizona State Retirement System now owns 10,550 shares of the company’s stock valued at $430,000 after purchasing an additional 611 shares during the last quarter. Johnson Investment Counsel Inc. lifted its position in Ingevity by 9.1% in the fourth quarter. Johnson Investment Counsel Inc. now owns 7,538 shares of the company’s stock valued at $307,000 after buying an additional 628 shares during the last quarter. Hudson Edge Investment Partners Inc. lifted its holdings in shares of Ingevity by 4.9% in the 4th quarter. Hudson Edge Investment Partners Inc. now owns 16,150 shares of the company’s stock worth $658,000 after acquiring an additional 750 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in shares of Ingevity by 6.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 12,097 shares of the company’s stock worth $493,000 after buying an additional 765 shares during the period. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. StockNews.com lowered shares of Ingevity from a “buy” rating to a “hold” rating in a research note on Monday, March 24th. BMO Capital Markets raised Ingevity from a “market perform” rating to an “outperform” rating and increased their price target for the company from $62.00 to $65.00 in a research report on Wednesday, February 26th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $55.17.

Ingevity Stock Down 0.3 %

Shares of NYSE NGVT opened at $39.62 on Monday. The business has a 50-day moving average of $45.16 and a two-hundred day moving average of $42.60. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of -3.35 and a beta of 1.53. Ingevity Co. has a 1 year low of $30.90 and a 1 year high of $56.30. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04.

Ingevity (NYSE:NGVT) last posted its earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.66. The firm had revenue of $298.80 million during the quarter, compared to analysts’ expectations of $297.40 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. On average, analysts forecast that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.